{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T04:30:44Z","timestamp":1717216244720},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s13730-017-0299-5","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T09:54:33Z","timestamp":1514541273000},"page":"77-82","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation"],"prefix":"10.1007","volume":"7","author":[{"given":"Daisuke","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihori","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasufumi","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Bokuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Sasaki-Yatabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Yatabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Onizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"key":"299_CR1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"299_CR2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1055\/s-0035-1565124","volume":"47","author":"A Prejbisz","year":"2015","unstructured":"Prejbisz A, Warchol-Celinska E, Lenders JW, Januszewicz A. Cardiovascular risk in primary hyperaldosteronism. Horm Metab Res. 2015;47:973\u201380.","journal-title":"Horm Metab Res"},{"key":"299_CR3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","volume":"33","author":"M Nishimura","year":"1999","unstructured":"Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, Kimura G. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis. 1999;33:261\u20136.","journal-title":"Am J Kidney Dis"},{"key":"299_CR4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/jc.2008-2245","volume":"94","author":"LA Sechi","year":"2009","unstructured":"Sechi LA, Di Fabio A, Bazzocchi M, Uzzau A, Catena C. Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab. 2009;94:1191\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"299_CR5","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C. Long-term renal outcomes in patients with primary aldosteronism. JAMA. 2006;295:2638\u201345.","journal-title":"JAMA"},{"key":"299_CR6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.ajkd.2016.04.011","volume":"68","author":"K Quach","year":"2016","unstructured":"Quach K, Lvtvyn L, Baigent C, Bueti J, Garg AX, Hawley C, Haynes R, Manns B, Perkovic V, Rabbat CG, Wald R, Walsh M. The safety and efficacy of mineralocorticoid receptor antagonists in patients who require dialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2016;68:591\u20138.","journal-title":"Am J Kidney Dis"},{"key":"299_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000345243","volume":"50","author":"M Briet","year":"2013","unstructured":"Briet M, Schiffrin EL. Vascular actions of aldosterone. J Vasc Res. 2013;50:89\u201399.","journal-title":"J Vasc Res"},{"key":"299_CR8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0895-7061(99)00066-7","volume":"12","author":"A Sato","year":"1999","unstructured":"Sato A, Funder JW, Saruta T. Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis. Am J Hypertens. 1999;12:867\u201373.","journal-title":"Am J Hypertens"},{"key":"299_CR9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.ajkd.2005.03.005","volume":"46","author":"E Gross","year":"2005","unstructured":"Gross E, Rothstein M, Dombek S, Juknis HI. Effect of spironolactone on blood pressure and the renin\u2013angiotensin\u2013aldosterone system in oligo-anuric hemodialysis patients. Am J Kidney Dis. 2005;46:94\u2013101.","journal-title":"Am J Kidney Dis"},{"key":"299_CR10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5414\/CN106973","volume":"76","author":"L Shavit","year":"2011","unstructured":"Shavit L, Neykin D, Lifschitz M, Slotki I. Effect of eplerenone on blood pressure and the renin\u2013angiotensin\u2013aldosterone system in oligo-anuric chronic hemodialysis patients\u2014a pilot study. Clin Nephrol. 2011;76:388 \u2013 95.","journal-title":"Clin Nephrol"},{"key":"299_CR11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/sdi.12421","volume":"29","author":"SD Suthar","year":"2016","unstructured":"Suthar SD, Middleton JP. Clinical outcomes in dialysis patients: prospects for improvement with aldosterone receptor antagonists. Semin Dial. 2016;29:52\u201361.","journal-title":"Semin Dial"},{"key":"299_CR12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","volume":"63","author":"Y Matsumoto","year":"2014","unstructured":"Matsumoto Y, Mori Y, Kageyama S, Arihara K, Sugiyama T, Ohmura H, Yakushigawa T, Sugiyama H, Shimada Y, Nojima Y, Shio N. Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients. J Am Coll Cardiol. 2014;63:528\u201336.","journal-title":"J Am Coll Cardiol"},{"key":"299_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1507\/endocrj.EJ13-0353","volume":"61","author":"Y Miyake","year":"2014","unstructured":"Miyake Y, Tanaka K, Nishikawa T, Naruse M, Takayanagi R, Sasano H, Takeda Y, Shibata H, Sone M, Satoh F, Yamada M, Ueshiba H, Katabami T, Iwasaki Y, Tanaka H, Tanahashi Y, Suzuki S, Hasegawa T, Katsumata N, Tajima T, Yanase T. Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study. Endocr J. 2014;61:35\u201340.","journal-title":"Endocr J"},{"key":"299_CR14","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00595-013-0828-6","volume":"44","author":"H Abe","year":"2014","unstructured":"Abe H. Mafune K. Risk factors for maintenance hemodialysis patients undergoing elective and emergency abdominal surgery. Surg Today. 2014;44:1906\u201311.","journal-title":"Surg Today"},{"key":"299_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","volume":"27","author":"M Omura","year":"2004","unstructured":"Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27:193\u2013202.","journal-title":"Hypertens Res"},{"key":"299_CR16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1507\/endocrj1954.36.681","volume":"36","author":"K Matsuda","year":"1989","unstructured":"Matsuda K, Shimamoto K, Ura N, Ogata H, Shizukuda Y, Iwakura M, Nozawa A, Kikuchi K, Iimura O. A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatment. Endocrinol Jpn. 1989;36:681\u20136.","journal-title":"Endocrinol Jpn"},{"key":"299_CR17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/ndt\/gfl702","volume":"22","author":"A Kazory","year":"2007","unstructured":"Kazory A, Weiner ID. Primary hyperaldosteronism in a patient with end-stage renal disease. Nephrol Dial Transplant. 2007;22:917\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"299_CR18","first-page":"21","volume":"56","author":"Y Kojima","year":"2010","unstructured":"Kojima Y, Miyake O, Morimoto A, Kawamura C, Katayama S. A case of aldosterone-producing adenoma associated with end-stage renal disease. Hinyokika Kiyo. 2010;56:21\u20134.","journal-title":"Hinyokika Kiyo"},{"key":"299_CR19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02082781","volume":"16","author":"T Nakada","year":"1984","unstructured":"Nakada T, Kimura M. Primary aldosteronism associated with chronic renal failure. Report of a case. Int Urol Nephrol. 1984;16:165\u201373.","journal-title":"Int Urol Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-017-0299-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-017-0299-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-017-0299-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T02:49:19Z","timestamp":1522896559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-017-0299-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,29]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["299"],"URL":"https:\/\/doi.org\/10.1007\/s13730-017-0299-5","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,29]]}}}